2022 Multidisciplinary Spine Oncology Symposium

Friday, April 22, 2022, 7:45 AM - 5:20 PM, Online

The Memorial Sloan Kettering Cancer Center 2022 Multidisciplinary Spine Oncology Symposium is focused on helping providers create multidisciplinary spine-tumor programs at their own institutions.

Spine tumor management has evolved dramatically over the past decade with the development of advanced radiation, surgical, and interventional techniques. The NOMS framework will be used as a foundation to provide attendees with the tools to integrate new technologies and evidence-based medicine that will lead to optimal care for your patients in a quickly changing oncology landscape.

This one-day live, virtual multidisciplinary series of lectures will provide information about the diagnosis and treatment of patients with spinal tumors. Surgical, interventional, radiation, and pharmacological treatment options will be discussed.

The program will consist of a series of lectures, case studies, and live Q&A with faculty.

Who Should Attend

This symposium is designed for physicians, physician extenders, and nurses in practice and training, in the fields of internal medicine, family practice, neurology, medical and radiation oncology, interventional and diagnostic radiology, pain management, physiatry, neurosurgery and orthopedic surgery who are interested in advancing their understanding of primary and metastatic spinal tumors.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

1. Describe the NOMS decision framework as the cornerstone of multidisciplinary care for spine tumors.
2. Recognize the ever expanding role of Spine Stereotactic Body Radiotherapy in the treatment of metastatic and primary spine tumors
3. Explore the evolution toward minimally invasive techniques in the treatment of spine metastases.
4. Assess when percutaneous cement augmentation is not enough in the treatment of pathologic fractures.
5. Discuss the complexities of spine-tumor rehabilitation.
6. Examine new techniques in oncologic pain management.
7. Define unique rehabilitation needs in the cancer patient.
8. Review integrated therapy in Neurofibromatosis.

Live Virtual Registration Fees

• Physicians (MDs, PhDs, and DOs): $150
• Residents, Fellows, Nurses, Techs, and Other Healthcare Providers: $100
• Industry Professionals*: $275

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

• A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend a MSK CME course. If you are a member of one of these groups, please contact [email protected] for details.
• Registration is complimentary for all MSK employees; however, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected]. 

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 7:00 AM on April 22, 2022. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MSK Course Directors 

Mark Bilsky, MD
Attending Neurosurgeon
Chief, Multi-Disciplinary Spine Tumor Service

Yoshiya (Josh) Yamada, MD
Attending Radiation Oncologist

 

Invited Course Faculty 

Kristin Janson Redmond, MD, MPH
Department of Radiation Oncology
Johns Hopkins
Baltimore, MD

John Shin, MD
Department of Neurosurgery
Massachusetts General Hospital
Boston, MA

 

MSK Course Faculty

Ori Barzilai, MD
Department of Neurosurgery

Victoria Brennan, MBBch, BAO
Department of Radiation Oncology

Aimee Crago, MD, PhD
Department of Surgery

Amitabh Gulati, MD
Department of Anesthesia Pain

Daniel S. Higginson, MD
Department of Radiation Oncology

Eric Lis, MD
Department of Interventional Radiology

Boris A. Mueller, MD, MPH
Department of Radiation Oncology

W. Christopher Newman, MD
Department of Neurosurgery

Anna F. Piotrowski, MD
Department of Neurology

Lisa Marie Ruppert, MD
Department of Rehab/Neurology

Adam Schmitt, MD
Department of Radiation Oncology

Max Vaynrub, MD
Department of Surgery

Divya Yerramilli, MD, MBE
Department of Radiation Oncology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, April 22, 2022

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

Globus Medical, Inc
Varian Medical Systems